Pharmaceutical anti - Buprenorphine Mouse Monoclonal Antibody for IVD research

Pharmaceutical anti - Buprenorphine Mouse Monoclonal Antibody for IVD research

Background:

Buprenorphine (C29 H41 NO4) is a prescription medication for people addicted to heroin or other opiates that acts by relieving the symptoms of opiate withdrawal such as agitation, nausea and insomnia. Buprenorphine is more weakly addictive and has a lower risk of overdose than methadone. The effects last for about three days.

Specification:

Product Overview: Monoclonal Antibody to Buprenorphine

Specificity: Buprenorphine

Immunogen: BUP-BSA conjugate

Isotype: IgG₁

Host animal: Mouse

Source: Ascites

Format: Purified, Lyophilized, Reconstitute in 100ul double distilled water.

Applications: Specific methodologies have not been tested using this product.

Purification: >95% pure (SDS-PAGE)

Affinity Constant: Not determined

Packing:

Concentration: 3.91mg/ml (OD280nm, E^0.1% = 1.4)

Buffer: PBS, pH 7.0

Preservative: 0.02% Sodium azide

Storage: Store lyophilized product at 2-8°C. After reconstitution, store at -20°C. Avoid multiple freeze/ thaw cycles.

Warning: This product contains sodium azide, which has been classified as Xn (Harmful) in European Di-rective 67/548/EEC in the concentration range of 0.1– 1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains.